Xvivo Perfusion AB
XVIVO.ST
#5149
Rank
NZ$2.11 B
Marketcap
$67.08
Share price
-1.14%
Change (1 day)
50.88%
Change (1 year)
Categories

Earnings for Xvivo Perfusion AB (XVIVO.ST)

Earnings in 2024 (TTM): NZ$6.13 Million

According to Xvivo Perfusion AB's latest financial reports the company's current earnings are NZ$73.21 Million. In 2023 the company made an earning of NZ$0.55 Million a decrease over its 2022 earnings that were of NZ$4.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xvivo Perfusion AB from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$6.13 M1004.73%
2023 NZ$0.55 M-86.2%
2022 NZ$4.02 M226.49%
2021 NZ$1.23 M-110.72%
2020 -NZ$11.5 Million-1221.07%
2019 NZ$1.02 M-70.61%
2018 NZ$3.48 M117.32%
2017 NZ$1.6 M146.09%
2016 NZ$0.65 M-61.52%
2015 NZ$1.69 M-3.88%
2014 NZ$1.76 M-39.59%
2013 NZ$2.91 M